 | • レポートコード：MRC2-11QY12076 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は成長ホルモン欠乏症治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）市場規模、用途別（病院、クリニック、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別成長ホルモン欠乏症治療の競争状況、市場シェア ・世界の成長ホルモン欠乏症治療市場：種類別市場規模 2015年-2020年（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術） ・世界の成長ホルモン欠乏症治療市場：種類別市場規模予測 2021年-2026年（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術） ・世界の成長ホルモン欠乏症治療市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅医療） ・世界の成長ホルモン欠乏症治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅医療） ・北米の成長ホルモン欠乏症治療市場分析：米国、カナダ ・ヨーロッパの成長ホルモン欠乏症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの成長ホルモン欠乏症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の成長ホルモン欠乏症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの成長ホルモン欠乏症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sandoz International、Sanofi Aventis、Pfizer、Novo Nordisk、Teva Pharmaceutical、Ranbaxy、EMD Serono、Sun Pharmaceutical、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.
The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults.
Market Analysis and Insights: Global Growth Hormone Deficiency Treatment Market
The global Growth Hormone Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Growth Hormone Deficiency Treatment Scope and Market Size
Growth Hormone Deficiency Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sandoz International
Sanofi Aventis
Pfizer
Novo Nordisk
Teva Pharmaceutical
Ranbaxy
EMD Serono
Sun Pharmaceutical
Eli Lilly
Market segment by Type, the product can be split into
Pharmacological Therapy
Recombinant Human Growth Hormone
Human Pituitary Gland Extracts
Surgery
Market segment by Application, split into
Hospitals
Clinics
Home Care Settings
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Growth Hormone Deficiency Treatment Revenue
1.4 Market by Type
1.4.1 Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Pharmacological Therapy
1.4.3 Recombinant Human Growth Hormone
1.4.4 Human Pituitary Gland Extracts
1.4.5 Surgery
1.5 Market by Application
1.5.1 Global Growth Hormone Deficiency Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care Settings
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Growth Hormone Deficiency Treatment Market Perspective (2015-2026)
2.2 Global Growth Hormone Deficiency Treatment Growth Trends by Regions
2.2.1 Growth Hormone Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Growth Hormone Deficiency Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Growth Hormone Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Growth Hormone Deficiency Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Growth Hormone Deficiency Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Growth Hormone Deficiency Treatment Players by Market Size
3.1.1 Global Top Growth Hormone Deficiency Treatment Players by Revenue (2015-2020)
3.1.2 Global Growth Hormone Deficiency Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Growth Hormone Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Growth Hormone Deficiency Treatment Market Concentration Ratio
3.2.1 Global Growth Hormone Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Growth Hormone Deficiency Treatment Revenue in 2019
3.3 Growth Hormone Deficiency Treatment Key Players Head office and Area Served
3.4 Key Players Growth Hormone Deficiency Treatment Product Solution and Service
3.5 Date of Enter into Growth Hormone Deficiency Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Growth Hormone Deficiency Treatment Historic Market Size by Type (2015-2020)
4.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
5.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Growth Hormone Deficiency Treatment Market Size (2015-2020)
6.2 Growth Hormone Deficiency Treatment Key Players in North America (2019-2020)
6.3 North America Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
6.4 North America Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Growth Hormone Deficiency Treatment Market Size (2015-2020)
7.2 Growth Hormone Deficiency Treatment Key Players in Europe (2019-2020)
7.3 Europe Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
7.4 Europe Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
8 China
8.1 China Growth Hormone Deficiency Treatment Market Size (2015-2020)
8.2 Growth Hormone Deficiency Treatment Key Players in China (2019-2020)
8.3 China Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
8.4 China Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Growth Hormone Deficiency Treatment Market Size (2015-2020)
9.2 Growth Hormone Deficiency Treatment Key Players in Japan (2019-2020)
9.3 Japan Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
9.4 Japan Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Growth Hormone Deficiency Treatment Market Size (2015-2020)
10.2 Growth Hormone Deficiency Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
11 India
11.1 India Growth Hormone Deficiency Treatment Market Size (2015-2020)
11.2 Growth Hormone Deficiency Treatment Key Players in India (2019-2020)
11.3 India Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
11.4 India Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Growth Hormone Deficiency Treatment Market Size (2015-2020)
12.2 Growth Hormone Deficiency Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Growth Hormone Deficiency Treatment Market Size by Type (2015-2020)
12.4 Central & South America Growth Hormone Deficiency Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sandoz International
13.1.1 Sandoz International Company Details
13.1.2 Sandoz International Business Overview
13.1.3 Sandoz International Growth Hormone Deficiency Treatment Introduction
13.1.4 Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2015-2020))
13.1.5 Sandoz International Recent Development
13.2 Sanofi Aventis
13.2.1 Sanofi Aventis Company Details
13.2.2 Sanofi Aventis Business Overview
13.2.3 Sanofi Aventis Growth Hormone Deficiency Treatment Introduction
13.2.4 Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.2.5 Sanofi Aventis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Growth Hormone Deficiency Treatment Introduction
13.3.4 Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Details
13.4.2 Novo Nordisk Business Overview
13.4.3 Novo Nordisk Growth Hormone Deficiency Treatment Introduction
13.4.4 Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.4.5 Novo Nordisk Recent Development
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Details
13.5.2 Teva Pharmaceutical Business Overview
13.5.3 Teva Pharmaceutical Growth Hormone Deficiency Treatment Introduction
13.5.4 Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.5.5 Teva Pharmaceutical Recent Development
13.6 Ranbaxy
13.6.1 Ranbaxy Company Details
13.6.2 Ranbaxy Business Overview
13.6.3 Ranbaxy Growth Hormone Deficiency Treatment Introduction
13.6.4 Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.6.5 Ranbaxy Recent Development
13.7 EMD Serono
13.7.1 EMD Serono Company Details
13.7.2 EMD Serono Business Overview
13.7.3 EMD Serono Growth Hormone Deficiency Treatment Introduction
13.7.4 EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.7.5 EMD Serono Recent Development
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Details
13.8.2 Sun Pharmaceutical Business Overview
13.8.3 Sun Pharmaceutical Growth Hormone Deficiency Treatment Introduction
13.8.4 Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.8.5 Sun Pharmaceutical Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Growth Hormone Deficiency Treatment Introduction
13.9.4 Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2015-2020)
13.9.5 Eli Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Growth Hormone Deficiency Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Growth Hormone Deficiency Treatment Revenue
Table 3. Ranking of Global Top Growth Hormone Deficiency Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacological Therapy
Table 6. Key Players of Recombinant Human Growth Hormone
Table 7. Key Players of Human Pituitary Gland Extracts
Table 8. Key Players of Surgery
Table 9. Global Growth Hormone Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Growth Hormone Deficiency Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Growth Hormone Deficiency Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Growth Hormone Deficiency Treatment Market Share by Regions (2015-2020)
Table 13. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Growth Hormone Deficiency Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Growth Hormone Deficiency Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Growth Hormone Deficiency Treatment Players
Table 20. Global Growth Hormone Deficiency Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Growth Hormone Deficiency Treatment Market Share by Players (2015-2020)
Table 22. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Treatment as of 2019)
Table 23. Global Growth Hormone Deficiency Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Growth Hormone Deficiency Treatment Product Solution and Service
Table 26. Date of Enter into Growth Hormone Deficiency Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Growth Hormone Deficiency Treatment Market Size Share by Type (2015-2020)
Table 30. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Growth Hormone Deficiency Treatment Market Size Share by Application (2015-2020)
Table 32. Global Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Growth Hormone Deficiency Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 36. North America Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 38. North America Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 42. Europe Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 44. Europe Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 48. China Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 50. China Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 54. Japan Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 56. Japan Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 60. Southeast Asia Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 66. India Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 68. India Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Growth Hormone Deficiency Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Growth Hormone Deficiency Treatment Market Share (2019-2020)
Table 72. Central & South America Growth Hormone Deficiency Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Growth Hormone Deficiency Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Growth Hormone Deficiency Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Growth Hormone Deficiency Treatment Market Share by Application (2015-2020)
Table 76. Sandoz International Company Details
Table 77. Sandoz International Business Overview
Table 78. Sandoz International Product
Table 79. Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 80. Sandoz International Recent Development
Table 81. Sanofi Aventis Company Details
Table 82. Sanofi Aventis Business Overview
Table 83. Sanofi Aventis Product
Table 84. Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 85. Sanofi Aventis Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Novo Nordisk Company Details
Table 92. Novo Nordisk Business Overview
Table 93. Novo Nordisk Product
Table 94. Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 95. Novo Nordisk Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceutical Recent Development
Table 101. Ranbaxy Company Details
Table 102. Ranbaxy Business Overview
Table 103. Ranbaxy Product
Table 104. Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 105. Ranbaxy Recent Development
Table 106. EMD Serono Company Details
Table 107. EMD Serono Business Overview
Table 108. EMD Serono Product
Table 109. EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 110. EMD Serono Recent Development
Table 111. Sun Pharmaceutical Business Overview
Table 112. Sun Pharmaceutical Product
Table 113. Sun Pharmaceutical Company Details
Table 114. Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 115. Sun Pharmaceutical Recent Development
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Product
Table 119. Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2015-2020) (Million US$)
Table 120. Eli Lilly Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Growth Hormone Deficiency Treatment Market Share by Type: 2020 VS 2026
Figure 2. Pharmacological Therapy Features
Figure 3. Recombinant Human Growth Hormone Features
Figure 4. Human Pituitary Gland Extracts Features
Figure 5. Surgery Features
Figure 6. Global Growth Hormone Deficiency Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Home Care Settings Case Studies
Figure 10. Growth Hormone Deficiency Treatment Report Years Considered
Figure 11. Global Growth Hormone Deficiency Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Growth Hormone Deficiency Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Growth Hormone Deficiency Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Growth Hormone Deficiency Treatment Market Share by Players in 2019
Figure 16. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Deficiency Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Growth Hormone Deficiency Treatment Revenue in 2019
Figure 18. North America Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Growth Hormone Deficiency Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ヒト成長ホルモン（hGH）の世界市場（～2026年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…- 第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
- チロシンヒドロキシラーゼ欠損症治療の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- ビタミン欠乏症治療の世界市場（～2026年） Vitamin deficiency, also called as hypovitaminosis, is primarily caused by malnutrition. The global vitamin deficiency treatment market is highly fragmented with large number of local as well as strong players. Market Analysis and Insights: Global Vitamin Deficiency Treatment Market The global Vitam…
- 亜鉛欠乏症治療の世界市場（～2026年） Fill zinc, it is the microelement zinc that compensatory human body needs, filling zinc is in human body growth development, immunity, vitamin to wait to having extremely important effect. Market Analysis and Insights: Global Zinc Deficiency Treatment Market The global Zinc Deficiency Treatment mark…